FDA Approved: ZYPREXA RELPREVV — Original Application (H2-Pharma LLC)

View source ↗

Summary

FDA approved ZYPREXA RELPREVV (olanzapine pamoate) under an Original Application, providing a long-acting injectable option for schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ZYPREXA RELPREVV (olanzapine pamoate)

Snippet

ORIG AP for ZYPREXA RELPREVV (OLANZAPINE PAMOATE)